PL2393476T3 - Kompozycje resweratrolu - Google Patents
Kompozycje resweratroluInfo
- Publication number
- PL2393476T3 PL2393476T3 PL10703803T PL10703803T PL2393476T3 PL 2393476 T3 PL2393476 T3 PL 2393476T3 PL 10703803 T PL10703803 T PL 10703803T PL 10703803 T PL10703803 T PL 10703803T PL 2393476 T3 PL2393476 T3 PL 2393476T3
- Authority
- PL
- Poland
- Prior art keywords
- resveratrol compositions
- resveratrol
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Virology (AREA)
- Mycology (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Colloid Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09152064 | 2009-02-04 | ||
EP10703803.6A EP2393476B1 (en) | 2009-02-04 | 2010-02-03 | Resveratrol compositions |
PCT/EP2010/000665 WO2010089104A2 (en) | 2009-02-04 | 2010-02-03 | Resveratrol compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2393476T3 true PL2393476T3 (pl) | 2016-07-29 |
Family
ID=42307936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL10703803T PL2393476T3 (pl) | 2009-02-04 | 2010-02-03 | Kompozycje resweratrolu |
Country Status (8)
Country | Link |
---|---|
US (1) | US8927046B2 (pl) |
EP (1) | EP2393476B1 (pl) |
JP (1) | JP5626809B2 (pl) |
KR (1) | KR101657326B1 (pl) |
CN (1) | CN102307568B (pl) |
ES (1) | ES2567782T3 (pl) |
PL (1) | PL2393476T3 (pl) |
WO (1) | WO2010089104A2 (pl) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2453765A4 (en) * | 2009-05-27 | 2013-02-20 | Kathryn Deibler | BEVERAGE PRODUCT WITH RESVERATROL |
EP2755639A2 (de) * | 2011-05-30 | 2014-07-23 | 2Lution GmbH | Feste lösungen von polyphenolen |
US9474715B2 (en) * | 2011-11-30 | 2016-10-25 | Andreas Voigt | Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition |
CN105188415A (zh) * | 2013-05-06 | 2015-12-23 | 帝斯曼知识产权资产管理有限公司 | 粉末状维生素e制剂 |
RU2549760C2 (ru) * | 2013-05-31 | 2015-04-27 | Михаил Юрьевич Сидоренко | Биологически активная добавка и способ ее получения |
KR101736098B1 (ko) | 2015-04-01 | 2017-05-17 | 영남대학교 산학협력단 | 수용성 레스베라트롤 조성물 및 이의 제조방법 |
EP3120838A1 (en) | 2015-07-20 | 2017-01-25 | Opterion Health AG | Aqueous solution comprising a polyphenol |
EP3334403B1 (en) | 2015-08-10 | 2021-03-31 | Mary Kay, Inc. | Topical compositions |
DE102015122672A1 (de) * | 2015-12-23 | 2017-06-29 | Brauns-Heitmann Gmbh & Co. Kg | Pulverförmige Eierfärbemittelzusammensetzung |
CN105616357A (zh) * | 2016-01-07 | 2016-06-01 | 郭敏 | 一种白藜芦醇干混悬剂及其制备方法 |
CN105878211B (zh) * | 2016-05-31 | 2019-02-19 | 肇庆巨元生化有限公司 | 一种冷水可分散的β-胡萝卜素微囊的制备方法 |
CN107714670A (zh) * | 2016-08-10 | 2018-02-23 | 北京万生药业有限责任公司 | 一种白藜芦醇纳米泡腾片 |
CA3040307A1 (en) * | 2016-10-20 | 2018-04-26 | Grunbiotics Pty Ltd | Oral medication formulations |
EP3698644A1 (en) * | 2019-02-20 | 2020-08-26 | Kl-Teho Oy | A fishing bait, a mouldable composition for manufacturing the fishing bait, a method for manufacturing the fishing bait and a use of the mouldable composition |
US11260025B1 (en) | 2021-02-15 | 2022-03-01 | King Abdulaziz University | In situ gelling composition as a pH-selective and mucoadhesive sustained release drug delivery system |
CN115844954B (zh) * | 2022-12-23 | 2023-07-07 | 同济大学 | 一种具有预防口腔疾病的片剂及其制备方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0665648B2 (ja) * | 1985-09-25 | 1994-08-24 | 塩野義製薬株式会社 | 白金系抗癌物質の安定な凍結真空乾燥製剤 |
DK546289D0 (da) | 1989-11-02 | 1989-11-02 | Danochemo As | Carotenoidpulvere |
ITMI20021074A1 (it) * | 2002-05-20 | 2003-11-20 | Actimex S R L | Composizione ternaria comprendente una sostanza attiva e processo di comacinazione per la sua preparazione |
KR101254454B1 (ko) * | 2003-05-27 | 2013-04-12 | 디에스엠 아이피 어셋츠 비.브이. | 신규한 기능식품 조성물 및 그의 용도 |
WO2005000258A1 (en) | 2003-06-27 | 2005-01-06 | Amorepacific Corporation | Self-assembled polymeric nanoparticles containing physiologically active ingredients and external application containing the nanoparticles |
MD2659C2 (ro) * | 2003-10-29 | 2005-08-31 | Институт Развития Интеллектуальной Собственности | Produs biologic activ pulverulent pe bază de vin roşu şi procedeu de obţinere a acestuia |
JP4471631B2 (ja) * | 2003-11-14 | 2010-06-02 | アサマ化成株式会社 | ブドウ由来物のリスベラトロールを用いる飲食品の色調保持方法および飲食品の色調保持剤 |
EP1928440A2 (en) * | 2005-05-25 | 2008-06-11 | Sirtris Pharmaceuticals, Inc. | Treatment of eye disorders with sirtuin modulators |
ITPD20050224A1 (it) * | 2005-07-19 | 2007-01-20 | Actimex Srl | Composizioni contenenti micronutrienti aventi in particolare attivita' antiossidante e loro impiego |
WO2007045488A1 (en) * | 2005-10-21 | 2007-04-26 | Dsm Ip Assets B.V. | Novel formulations of fat-soluble active ingredients with high bioavailability |
RU2449554C2 (ru) * | 2006-02-01 | 2012-05-10 | Нестек С.А. | Пищевые системы и способы увеличения долголетия |
ATE464890T1 (de) * | 2006-03-28 | 2010-05-15 | Epitech Group Srl | Eine pharmazeutische zusammensetzung zur behandlung von pathologien, die durch die allgemeine immunantwort verursacht werden |
EP2172118A3 (en) | 2006-06-13 | 2011-09-07 | IdeaMed LLC | Fluid compositions comprising polyphenols and methods for making and packaging the same |
CN101292966A (zh) * | 2007-04-29 | 2008-10-29 | 沈阳皓天万嘉医药科技有限公司 | 一种白藜芦醇及苷的固体分散体及其制备方法 |
-
2010
- 2010-02-03 ES ES10703803.6T patent/ES2567782T3/es active Active
- 2010-02-03 KR KR1020117020518A patent/KR101657326B1/ko active IP Right Grant
- 2010-02-03 EP EP10703803.6A patent/EP2393476B1/en active Active
- 2010-02-03 JP JP2011546721A patent/JP5626809B2/ja not_active Expired - Fee Related
- 2010-02-03 PL PL10703803T patent/PL2393476T3/pl unknown
- 2010-02-03 US US13/147,885 patent/US8927046B2/en not_active Expired - Fee Related
- 2010-02-03 WO PCT/EP2010/000665 patent/WO2010089104A2/en active Application Filing
- 2010-02-03 CN CN201080006674.2A patent/CN102307568B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2567782T3 (es) | 2016-04-26 |
CN102307568B (zh) | 2014-12-24 |
CN102307568A (zh) | 2012-01-04 |
WO2010089104A2 (en) | 2010-08-12 |
EP2393476A2 (en) | 2011-12-14 |
EP2393476B1 (en) | 2016-01-13 |
KR20110118705A (ko) | 2011-10-31 |
WO2010089104A3 (en) | 2011-01-06 |
JP5626809B2 (ja) | 2014-11-19 |
US20120045563A1 (en) | 2012-02-23 |
KR101657326B1 (ko) | 2016-09-19 |
JP2012516834A (ja) | 2012-07-26 |
US8927046B2 (en) | 2015-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL217949A0 (en) | Pesticdal compositions | |
EP2488022A4 (en) | Compositions | |
ZA201109176B (en) | Homeglobin compositions | |
GB0908129D0 (en) | Composition | |
GB0906515D0 (en) | Fungical compositions | |
PL2393476T3 (pl) | Kompozycje resweratrolu | |
GB0918450D0 (en) | Composition | |
ZA201109312B (en) | Compositions | |
GB0909362D0 (en) | Composition | |
GB0908642D0 (en) | Composition | |
GB0901966D0 (en) | Composition | |
EP2394634A4 (en) | HESPERIDO-CONTAINING COMPOSITION | |
GB0906779D0 (en) | Composition | |
GB0922389D0 (en) | composition | |
GB0911294D0 (en) | Composition | |
GB0904941D0 (en) | Composition | |
EP2485807A4 (en) | SUN PROTECTION COMPOSITIONS | |
EP2444061A4 (en) | COMPOSITION CONTAINING APIGENIN | |
GB0905165D0 (en) | Compositions | |
GB0906548D0 (en) | Composition | |
GB0904942D0 (en) | Composition | |
GB0918590D0 (en) | Composition | |
GB0903688D0 (en) | Composition | |
GB0922133D0 (en) | Composition | |
GB0902959D0 (en) | Composition |